Page 2872 - Cote clinical veterinary advisor dogs and cats 4th

Boldface page numbers indicate chapter titles. Page numbers followed by a indicate algorithms; b, boxes; e, electronic content; f, figures; and t, tables. 1519

Brown recluse spider, 928–929 Burns, 138–140, 1403.e3a Calcium carbonate
Brucella canis, 138.e3–138.e6, 266, 1172.e2t–1172.e3t Burr cells. See Acanthocytes administration and dosage of, 1466
parturition and, 759
BuSpar. See Buspirone
Brucella slide agglutination, 1319
VetBooks.ir Brucella tularensis. See Francisella tularensis Buspirone Calcium channel blockers. See also specific drugs
for atrial fibrillation, 95–96
administration and dosage of, 1465
Brucellosis
abortion and, 2–3
for aggression in cats, 39
for atrial tachycardia, 97
for inappropriate elimination, in cats, 534
canine, 138.e3–138.e6, 138.e5f
discospondylitis and, 267t Busulfan, 1465 for glomerulonephritis, 391
for hypertension, 502
Brugia pahangi, 602.e2 Butazolidin. See Phenylbutazone toxicosis from, 140–141
Brunfelsia toxicosis, 138.e6–138.e7 Butorphanol Calcium chloride, for calcium channel blocker toxicosis,
Brussels griffon, Chiari-like malformation in, 156 adverse effects of, 1510.e6t 141
BSE (bovine spongiform encephalopathy), 937.e2 for bordetellosis, 126 Calcium EDTA
Bubonic plague, 790.e3 for chronic bronchitis, 137 administration and dosage of, 1200t–1201t, 1466
Buccal mucosal bleeding time, 1076, 1076f for collapsing trachea, 194 for lead toxicosis, 579
Budesonide as cough suppressant, 218 for zinc toxicosis, 1053
administration and dosage of, 1465 for dilated cardiomyopathy, 265 Calcium gluconate
for colitis, 192 for feline lower urinary tract signs, 333t for calcium channel blocker toxicosis, 141
for inflammatory bowel disease, 545 for neck pain, 684 for dystocia, 280
Buffy coat analysis, 1320 for pancreatitis, 741, 743 for eclampsia, 282
Bufo toad toxicosis, 978–979 for panosteitis, 750 for hyperkalemia, 496
Bulbar paralysis. See Pseudorabies for sedation, 522 for hypocalcemia, 516
Bull mastiff sensitivity to, MDR1 mutation and, 639 for phosphate enema toxicosis, 788.e2
cutaneous neoplasia in, 230 Butterfly vertebrae, 933.e2 toxicosis, 141
ectropion in, 296 Calcium infusion, ECG monitoring during, 516
familial nephropathy in, 169 C Calcium oxalate dihydrate crystals, 1290, 1332f
lymphoma in, 609 C sign, 377 Calcium oxalate monohydrate crystals, 1290, 1332f
Bull terrier Cabergoline, 540 Calcium oxalate urolithiasis. See Oxalate urolithiasis
familial nephropathy in, 169 for acromegaly, 19 Calcium phosphate crystals, 1290, 1332f
laryngeal paralysis in, 574 administration and dosage of, 1466 Calcium phosphate urolithiasis, 1014.e2–1014.e4
lethal acrodermatitis in, 214 for eclampsia, 282 Calcium salts, 1205
miniature, mitral valve dysplasia in, 657 for galactostasis, 571 Calcium stimulation test, 382.e2
mitral valve dysplasia in, 657 for mastitis, 620 Calcium:phosphorus ratio, nutritional secondary
nasal cutaneous disorders in, 676 for pregnancy termination, 819 hyperparathyroidism and, 697
nephrotic syndrome in, 691 for pseudocyesis, 832 Calculi, urinary. See Urolithiasis
obsessive-compulsive disorder in, 702 for pyometra, 855 Calicivirus, feline. See Feline calicivirus (FCV)
pigmentary abnormalities in, 195 Cachexia. See also Weight loss Callus pyoderma, 852
polycystic kidney disease in, 805 cancer-associated, 754–756, 1263 Calluses, 143.e2–143.e3
protein-losing nephropathy in, 830.e2 cardiac, 140.e1–140.e4 Caloric requirement estimation, 1048
stunted growth in, 946 paraneoplastic syndromes and, 754 Calorie needs calculation, 1077
Bulla osteotomy, for nasopharyngeal polyp, 682 Cadaverine, 346 Calstabin-2, 77
Bullae, pulmonary, 834–835 Cadmium, in adulterated diets, 37t Campylobacter spp.
Bulldog. See also English bulldog; French bulldog Caffeine toxicosis, 160t abortion and, 2
hydrocephalus in, 481 Cairn terrier C. jejuni gastroenteritis, 811
hypoplastic trachea in, 521 aseptic necrosis of femoral head in, 80 chronic diarrhea and, 262
lymphoma in, 609 familial nephropathy in, 169 enteritis and, 143.e3–143.e4
pericardial effusion in, 773 glaucoma in, 387 Canaliculi, 237.e1
pyloric outflow obstruction in, 851.e2 hydrocephalus in, 481 Cancellous autografts, 1068.e2
pyoderma in, 851 inguinal hernia in, 549 Cancer. See Neoplasia
tail paralysis in, 957 iris abnormalities in, 563 Cancer-associated cachexia, 754–756, 1263
vaginal hyperplasia/prolapse in, 1028 obesity in, 700 Cancer-associated weight loss. See Cachexia,
Bullets, 400 pyruvate kinase deficiency in, 59 cancer-associated
Bullous emphysema, 834. See also Pulmonary bullae and stunted growth in, 946 Candidatus Mycoplasma haemominutum, 438–440
blebs Calan. See Verapamil Candidatus Mycoplasma turicensis, 438–440
BUN. See Blood urea nitrogen (BUN) Calcaneal tendon, common, rupture of. See Achilles Candiduria, 234.e2
Bundle branch block tendon injury Canine acne, 852. See also Acne
left, 579.e2–579.e3, 579.e2f Calcet. See Calcium gluconate Canine adenovirus-1 (CAV-1), 201, 454.e2
right, 891.e2–891.e3, 891.e2f Calciferol. See Ergocalciferol abortion and, 2
Buphthalmos, 705–706 Calcification, skin. See Calcinosis cutis/circumspecta canine infectious hepatitis and, 454.e2
glaucoma and, 387 Calcijex. See Calcitriol (1,25–dihydroxycholecalciferol) conjunctivitis and, 201
Bupivacaine, 1100.e2 Calcimar. See Calcitonin Canine adenovirus-2 (CAV-2)
Buprenex. See Buprenorphine Calcinosis cutis/circumspecta, 140.e4–140.e6, infectious tracheobronchitis and, 988
Buprenorphine, 1100.e2 140.e5f–140.e6f viral respiratory disease caused by, 1039.e2
administration and dosage of, 1465 Calcipotriene toxicosis, 164–165 Canine alopecia, 47–48, 47f
for bite-related pain, 120.e3 Calcipotriol, 164 diagnostic approach to, 1400a
for feline lower urinary tract signs, 333t Calcitonin symmetrical, causes of, 1195–1196
fetal adverse effects and, 818 administration and dosage of, 1466 Canine coronavirus (CCV), 217.e2
for hip dysplasia, 470 in calcium regulation, 515 Canine Cushing’s syndrome, 485
for neck pain, 684 for hypercalcemia, 492 Canine cyclic hematopoiesis, 195
for necrotizing fasciitis, 685 for hypercalcemia of malignancy, 606 Canine degenerative radiculomyelopathy. See
for pain, 339 Calcitriol (1,25–dihydroxycholecalciferol) Degenerative myelopathy
for pancreatitis, 741, 743 administration and dosage of, 1466 Canine distemper testing, protective antibody titer for,
Burmese cat for hypocalcemia, 516 1321
alopecia in, 45 for hypoparathyroidism, 520 Canine distemper virus, 271–273
corneal sequestration in, 208 for renal dysplasia, 876 conjunctivitis and, 201
diabetes mellitus in, 251 for renal secondary hyperparathyroidism, 879 serologic testing for, 1321
dilated cardiomyopathy in, 263 toxicosis from, 164–165 Canine dracunculiasis, 275.e1
familial nephropathy in, 169 Calcium Canine guinea-worm. See Dracunculus insignis infection
hyperlipidemia in, 497 deficiency of, and hyperparathyroidism, 698 Canine heartworm disease. See Heartworm disease
intussusception in, 561 homeostasis of, 515 Canine herpesvirus 1 (CHV-1), 3, 466–467
neck ventroflexion in, 684.e2 oral supplementation of abortion and, 2
nystagmus in, 699 for eclampsia, 282 vaccine for, 3
obsessive-compulsive disorder in, 702 for hypocalcemia, 516 Canine hyperestrogenism, 495.e2–495.e3
restrictive/unclassified cardiomyopathy in, 881 serum levels of, 1320–1321 Canine infectious hepatitis (CIH), 454.e2–454.e3
tetraplegia/tetraparesis in, 967 decreased. See Hypocalcemia Canine infectious respiratory disease complex (CIRDC),
third eyelid disorders in, 970 increased. See Hypercalcemia 987, 1039.e2
www.ExpertConsult.com